Featured Products & Services

1. ÄKTA oligosynt™ Oligonucleotide Synthesizer 3/28/2022

   The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.

2. Automated Single-Use Filtration System For Small-Scale Manufacturing 11/15/2017

   This automated single-use filtration system for pilot- and small-scale manufacturing features a single-use flow path that addresses the bioburden challenge, reducing the need for cleaning to shorten batch changeover time.

3. Clinical And Regulatory Strategy 11/7/2023

   Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.

4. BioPAT® SIMCA: Process Characterization Software 4/25/2017

   BioPAT® SIMCA software tool for scientists, engineers, researchers, product developers and others striving to gain information from large quantities of data.

5. Infectious Diseases And Vaccines CRO Services 6/27/2023

   Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.

6. Pharmacometric Services 6/27/2023

   Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.

7. Bionanoparticle Technology 4/24/2023

   Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.

8. Biologics Manufacturing 5/15/2024

   ReciBioPharm GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.

9. Virosart® Media Lab Modules 6/13/2016

   Virus-retentive filtration is a highly efficient method for viral risk mitigation of cell culture media. This filter targets both non-enveloped viruses, such as MVM and vesivirus, and large enveloped viruses, such as MLV. Virosart® Media is especially designed for virus filtration of chemically defined cell culture media.

10. New Solutions For Large Molecule Analysis 6/16/2023

    Explore Biozen LC Portfolio

    With a new titanium BioTi™ biocompatible hardware to minimize priming, four particle platforms for optimal versatility and nine particle chemistries to maximize selectivity and sensitivity, Biozen UHPLC/HPLC columns are seamlessly designed to bring peace of mind to your analysis of biologics through:

    • Charge Variant Analysis
    • Aggregate Analysis
    • Peptide Mapping
    • Intact Mass Intact and Fragment Analysis
    • Glycan Analysis
    • Peptide Quantitation
    • Drug Antibody Ratio (DAR)
    • Oligonucleotide Characterization